CHEK2 and breast cancer: Moreover, a worse distant disease-free survival and overall survival (OS) for CHEK2 1100delC BC patients have been reported (de Bock et al. 2004; Kriege et al. 2014; Schmidt et al. 2007; Weischer et al. 2012).